RBC Capital initiated coverage of GE HealthCare Technologies with an Outperform rating and an $80 price target on June 23. The analyst cited an attractive risk-reward profile, stronger R&D spending, and improved commercial execution since the company's 2023 separation from General Electric, along with a solid order backlog expected to support faster growth later in 2026. Separately, on June 9, GE HealthCare announced it will showcase its latest cloud-enabled enterprise imaging technologies, including the Genesis Radiology Workspace and InteleShare, at the SIIM 2026 Annual Meeting.
GE HealthCare Technologies Inc.RBC Capital initiated coverage with Outperform rating and $80 price target, citing attractive risk-reward and growth prospects
GE Aerospace